Pressreleases

E-Commerce to be a Lucrative Distribution Channel for Sales of Schizophrenia Treatment Products : Persistence Market Research

Several factors impacting the growth of the schizophrenia treatment market has been covered in an extensive research report titled “Schizophrenia Treatment Market: Global Industry Analysis (2012-2016) and Forecast (2017-2027)”. Persistence Market Research has presented all the facets of the market in a systematic manner outlining various opportunities, trends, key developments, key market players and growth influencing aspects. The research report presents a forecast analysis for a period of 10 years, starting from 2017 till 2027 along with historical data.

Innovations in Healthtech and Pharma to Redefine Treatment for Insomnia : Persistence Market Research

Technological innovations have revolutionized lifestyle, communication, business, travel, and healthcare. The healthcare technology industry is continually improving ways to treat neural-related medical conditions, coupled with a significant understanding of subsequent ramifications and consequences. On the other hand, the pharmaceutical landscape has also transitioned and opened itself to explore novel scientific approaches and innovative technologies within its core therapeutic areas.

New Pharma Biotech eLearning Available from NSF

NSF have added two new eLearning sessions to its online portal. NSF’s new pharma biotech eLearning includes short, targeted, highly focused “how to” sessions on common industry themes as well as introductions and overviews on topics essential for those new to the industry. Learn from NSF’s trusted industry experts and take away tools and techniques that can be used instantly in the workplace.

Significant Product Pipeline and Emerging Opportunity in Biosimilars Trending the Non-Infectious Macular Edema Treatment Market : Persistence Market Research

The ophthalmology sector has gained massive traction during the course of the last few years. This is a result of growing prevalence of diseases like macular edema, which is a severe case of swelling in the retina possibly leading to blindness. Looking at the significant increase in the number of macular edema cases, many new drugs have been introduced in the global market and several are still in the pipeline. Anti-VEGF and corticosteroid therapies are considered to be the standard therapies for prevention of vision loss in patients in various indications of macular edema. The other drug types that are part of the macular edema treatment market are immunosuppressant and biologics, and many new treatment types are expected to be introduced as the market continues to grow. The outcomes of a recent market research by Persistence Market Research has revealed the growth of the global non-infectious macular edema treatment market at a CAGR of 7.0% during the forecast period 2018-2026. The study also projects the market to reach a valuation of over US$ 17,200 Mn by the end of 2026.

Pfanstiehl D-Galactose Products for Cell Culture Media Optimisation

As part of Pfanstiehl’s continual commitment to producing high-purity, low-endotoxin and low-metal (HPLE-LM) offerings for bioprocessing components, two new D-Galactose products were launched.

ZEMAC Copolymer Technology for Adhesives and Coatings Applications

Vertellus has announced it is introducing ZeMac copolymer technology to the coating and adhesive marketplace. This innovative technology is an

Butterworth Laboratories Announces New Facility in Hampton, UK

UK contract analytical chemistry provider Butterworth Laboratories is delighted to announce it has secured a facility in Hampton, Middlesex.

Hierarchy For Capa Effectiveness

Have you ever reviewed an investigation report and wondered whether the proposed corrective and preventive action (CAPA) would be effective?

Sometimes, we shrug our shoulders and say, “At least they put something in place”. We all know that the FDA expects us to include an effectiveness check, but do we have enough guidance to make these checks meaningful? NSF suggests that you consider these three questions:
1. What will you measure?
2. When will you measure it?
3. What is your acceptance standard?

Upcoming Pharmaceutical Courses from NSF

Make sure you remember to take advantage of any discounts you could be entitled to! Get in touch if you're interested in bringing any of this training on-site.